Patient Empowerment in ER-Positive, HER2-Negative Metastatic Breast Cancer Care

In this closing segment, Dr. Gregory Vidal discusses the importance of patient engagement and empowerment throughout the course of ER-positive, HER2-negative metastatic breast cancer. He encourages patients to actively participate in conversations with their care team by asking thoughtful questions about treatment goals, expected side effects, monitoring plans, and available options if the disease progresses. Dr. Vidal emphasizes that informed patients are better equipped to make shared decisions that align with their personal values and quality-of-life priorities. He also highlights the role of caregivers in supporting communication and helping patients process complex medical information. By fostering open dialogue and maintaining a collaborative approach, patients can feel more confident and prepared as they navigate treatment transitions. This segment reinforces that managing ER-positive, HER2-negative metastatic breast cancer is a continuous process that benefits from clear communication, education, and a strong partnership between patients and their oncology care team.